User Stats

Rank: 486
Karma Score: 1,319
Joined: January 13, 2022
Submitted Stories: 367
Published Stories: 6514
Comments: 24
Votes: 367
Group Name
Membership unavailable

Following

No Following!

Followers

No Follower!

Stories

1

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Hepatitis C Virus Envelope Protein E1 targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Hepatitis C Virus Envelope Protein E1 targeted therapeutics development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

1

Angola Beverages Consumption Trends and Forecasts Tracker, Q2 2022 (Dairy and Soy Drinks, Alcoholic Drinks, Soft Drinks and Hot Drinks)

The Angola beverages market size was 553.3 million liters (ML) in Q1 2022. The Angola beverages market report, covering soft drinks, dairy drinks, hot drinks, and alcoholic drinks is an essential tool for keeping up to date with the latest industry performance and developments on a quarterly basis. The key segments in the Angola beverages market are soft drinks, hot drinks, dairy and soy drinks and milk alternatives, and alcoholic drinks. Soft drinks had the highest volume in the Angola beverages market in Q2 2022.

Soft Drinks

Soft drinks can be further segmented into packaged water, flavored water, carbonates, juice, nectars, still drinks, squash/syrups, fruit powders, iced/RTD tea drinks, iced/RTD coffee drinks, sports drinks, energy drinks, and bulk/HOD water. In Q2 2022, within the segment, carbonates had the highest volume in the Angola beverages market.

Hot Drinks

Hot drinks can be further segmented into hot coffee, hot tea, and other hot drinks. In Q22022, within the segment, hot coffee had the highest volume in the Angola beverages market.

1

Algeria Beverages Consumption Trends and Forecasts Tracker Q2 2022

The key categories in the Algeria beverages market are soft drinks, hot drinks, alcoholic drinks, and dairy & soy drinks & milk alternatives. Soft drinks had the highest market share in the Algeria beverages market in Q1 2022.

Soft Drinks: The soft drinks category can be further segmented into packaged water, carbonates, juice, nectars, still drinks, squash/syrups, fruit powders, iced/RTD tea drinks, iced/RTD coffee drinks, sports drinks, and energy drinks. Packaged water was the largest segment in the Algeria soft drinks category in Q1-2022.

Hot Drinks: The hot drinks category can be further segmented into hot coffee, hot tea, and other hot drinks. Hot coffee was the largest segment in the Algeria hot drinks category in Q1-2022.

Alcoholic Drinks: The alcoholic drinks category can be further segmented into beer, flavored alcoholic beverages, fortified wine, brandy, gin & genever, liqueurs, rum, sparkling wine, still wine, tequila & mezcal, vodka, and whiskey. Beer was the largest segment in the Algeria alcoholic drinks category in Q1-2022.

1

Ghana Insurance Industry – Key Trends and Opportunities to 2025

The Ghana insurance market size was $764.6 million in 2021. The market is expected to grow at a CAGR of more than 17% from 2020 to 2025.

The Ghana insurance market research report provides a detailed outlook by product category for the Ghanaian insurance industry. It provides values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability ratios, and premium by line of business, during the review period and forecast period. The report also analyzes distribution channels operating in the segment and gives a comprehensive overview of the Ghanaian economy and demographics. Moreover, it provides detailed information on the competitive landscape in the country and includes details of insurance regulations and recent changes in the regulatory structure.

1

Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

The gastroparesis pipeline consists of 17 pharmaceuticals spanning all stages of development, with approximately 90% of the drugs in early-stage development. Antagonists targeting the D2 receptor are expected to remain an important mechanism of action within the gastroparesis space. The report provides a data-driven overview of the current and future competitive landscape in gastroparesis therapeutics.

Gastroparesis is a chronic disease characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction of the stomach. Patients with gastroparesis experience chronic symptoms with episodes of exacerbation, which typically include postprandial fullness, nausea, vomiting, and upper abdominal pain. Patients may also present with gastroparesis-like symptoms without delayed gastric emptying, complicating the identification of patients with the disease. The overlap of upper gastrointestinal symptoms makes the distinction between gastroparesis and other disorders, such as functional dyspepsia, more challenging.

Gastroparesis is more than twice as common in females as in males. Caucasians have the highest prevalence of any type of gastroparesis across all ages, followed by African Americans. Diabetic gastroparesis patients had a significantly higher risk of mortality than those with idiopathic gastroparesis in the UK. Gastroparesis is largely undiagnosed because many patients with diabetic gastroparesis are asymptomatic.

1

Friedreich Ataxia – Global Clinical Trials Review 2022

The key regions in the Friedreich ataxia clinical trials market are Asia-Pacific, Europe, North America, and Central & South America.

Friedreich ataxia clinical trials market in Asia-Pacific

The top four countries in Asia-Pacific in the Friedreich ataxia clinical trials market are Australia, Japan, New Zealand, and South Korea. Australia has the highest number of clinical trials, followed by Japan, New Zealand, and South Korea.

Friedreich ataxia clinical trials market in Europe

The top five countries in Europe in the Friedreich ataxia clinical trials market are Italy, France, Austria, Spain, and the UK. Italy has the highest number of clinical trials, followed by France, Austria, Spain, and the UK.

Friedreich ataxia clinical trials market in North America

The top two countries in the Friedreich ataxia clinical trials market in North America are the US and Canada. The US have the highest number of clinical trials, followed by Canada.

1

Denmark Renewable Energy Policy Handbook 2022 Update

What are the market dynamics in Denmark's renewable energy industry? The Danish Energy Agency (DEA), established under the Ministry of Climate, Energy & Utilities, is responsible for energy production, supply, and consumption in the country. In June 2018, the Danish government signed an energy agreement which constituted a framework for Denmark’s policy on climate and energy, up to 2020 and outlines further to 2050. According to the agreement, Denmark aimed to source a higher percentage of renewable energy than the European Commission’s (EU) binding target for the country. Denmark also committed to meeting an ambitious binding target to reduce greenhouse gases (GHGs) in sectors outside the Danish Emission Trading System (ETS). The Catalogue of Danish Climate Change Mitigation Measures describes several possible policies and measures to mitigate climate change, including the use of wind power and the electric car.

1

Cryptococcal Meningitis Drugs in Development by Stages Target MoA RoA Molecule Type and Key Players

Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cryptococcal Meningitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptococcal Meningitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

1

Corrosive Esophagitis Erosive Esophagitis Drugs in Development by Stages Target

Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Corrosive Esophagitis (Erosive Esophagitis) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Corrosive Esophagitis (Erosive Esophagitis), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

1

France Fresh Fish and Seafood Counter Fish and Seafood Market Size Growth and Forecast Analytics to 2025

Fresh Fish & Seafood (Counter) (Fish & Seafood) Market in France – Outlook to 2025; Market Size, Growth and Forecast Analytics is a broad level market review of Fresh Fish & Seafood (Counter) market in France.

Fresh Fish & Seafood (counter) – fresh fish and seafood, whether whole pieces or whole cuts, sold over fishmongers' counters in retailers.

Fresh Fish & Seafood (Counter) market in France registered a positive compound annual growth rate (CAGR) of 2.54% during the period 2015 to 2020 with a sales value of EUR 1,877.59 Million in 2020, a decrease of -2.29% over 2019. The market achieved its strongest performance in 2018, when it grew by 4.39% over its previous year and its weakest performance in 2020, when it fell by -2.29% over 2019.

The research handbook provides up-to-date market size data for period 2015-2020 and illustrative forecast to 2025 premised on Covid-19 hit, covering key market aspects like Sales Value and Volume for Fresh Fish & Seafood (Counter) and its variants .

1

Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Extrahepatic Bile Duct Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Extrahepatic Bile Duct Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data. * Global Markets Direct, is a research brand owned and operated by GlobalData.

1

Electric Vehicles EV Thematic Research

There were 10.74 million electrified vehicles (EVs) on the road globally by the end of 2021. The transition to electrification is creating unprecedented disruption in the auto industry. Original equipment manufacturers (OEMs) with more than a century of experience building combustion-powered vehicles are now battling overcapacity across their production networks and face big costs to retool their factories. Meanwhile, EV startups have emerged to meet swelling demand.

The widely reported environmental damage from combustion-powered transport has led governments around the world to announce cut-off dates for the sale of combustion-powered light vehicles. This is being met by growing consumer demand for EVs led by desirable models from both novel startups and established players.

The electric vehicles thematic report looks at the electric vehicles theme – principally, battery electric vehicles (BEVs). These models demand new technologies and components that were previously uncommon in vehicles, especially in the field of lithium-ion batteries, which are not a core competency for most traditional automakers.

1

Endocarditis Drugs in Development by Stages Target MoA RoA Molecule Type

Endocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Endocarditis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Endocarditis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

1

Dyskinesia Drugs in Development by Stages Target MoA RoA Molecule Type

Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movements. Its symptoms include facial grimacing, finger movement, jaw swinging, repetitive chewing, and tongue thrusting. However, the disease can be controlled by a healthy lifestyle and medication.

The Dyskinesia pipeline market research report provides comprehensive information on the therapeutics under development for Dyskinesia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dyskinesia and features dormant and discontinued projects

1

Turkey Geothermal Power Market Size and Trends by Installed Capacity

The Turkey geothermal power market cumulative installed capacity was 1.68 GW in 2021. The market is expected to grow at a CAGR of more than 5% from 2021 to 2035. The Turkey geothermal power market research report offers comprehensive information and understanding of the geothermal power market in Turkey. The report discusses the renewable power market in the country and provides forecasts for up to 2035. It also highlights installed capacity and power generation trends from 2010 to 2035 in the country’s geothermal power market. Moreover, it provides detailed coverage of the renewable energy policy framework governing the market and company snapshots of some of the major market participants.

1

Aesthetic Injectables Pipeline Report including Stages of Development

Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. GlobalData's Medical Devices sector report, “Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Aesthetic Injectables report provides key information and data related to:

Extensive coverage of the Aesthetic Injectables under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

1

Automotive Autonomous Vehicles Market and Trend Analysis by Technology, Key Companies and Forecast, 2021-2036

The Society of Automotive Engineers (SAE) International’s J3016 provides a common taxonomy and definitions for automated driving to simplify communication and facilitate collaboration within technical and political domains and provides full descriptions and examples for each level. The Autonomous Vehicles Market and Trend Analysis report provides a comprehensive overview of the emerging autonomous light vehicle sector, major suppliers, top 14 markets, technology trends, and market size forecasts.